Literature DB >> 3121012

Does captopril exacerbate psoriasis?

N W Hamlet, M Keefe, R E Kerr.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3121012      PMCID: PMC1248423          DOI: 10.1136/bmj.295.6609.1352

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  5 in total

1.  Severe cutaneous reactions to captopril.

Authors:  M J Goodfield; L G Millard
Journal:  Br Med J (Clin Res Ed)       Date:  1985-04-13

2.  Absence of cross-reactivity between captopril and enalapril.

Authors:  G J Navis; P E de Jong; C G Kallenberg; J de Monchy; D de Zeeuw
Journal:  Lancet       Date:  1984-05-05       Impact factor: 79.321

3.  Captopril and enalapril.

Authors:  I Gavras; H Gavras
Journal:  Ann Intern Med       Date:  1983-04       Impact factor: 25.391

4.  The captopril-induced eruption. A possible mechanism: cutaneous kinin potentiation.

Authors:  J K Wilkin; J J Hammond; W M Kirkendall
Journal:  Arch Dermatol       Date:  1980-08

5.  Captopril: 4 years of post marketing surveillance of all patients in New Zealand.

Authors:  I R Edwards; D M Coulter; D M Beasley; D MacIntosh
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

  5 in total
  2 in total

Review 1.  Psoriasis After Exposure to Angiotensin-Converting Enzyme Inhibitors: French Pharmacovigilance Data and Review of the Literature.

Authors:  Brahim Azzouz; Aurore Morel; Lukshe Kanagaratnam; Emmanuelle Herlem; Thierry Trenque
Journal:  Drug Saf       Date:  2019-12       Impact factor: 5.606

2.  A systematic review and meta-analysis of angiotensin-converting enzyme inhibitor use and psoriasis incidence.

Authors:  Gonjin Song; Ji Yea Kim; Ha Young Yoon; Jeong Yee; Hye Sun Gwak
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.